1. Steroid elimination-who, when, how?
- Author
-
Matas AJ
- Subjects
- Antilymphocyte Serum therapeutic use, Clinical Trials as Topic, Drug Administration Schedule, Drug Therapy, Combination, Graft Rejection epidemiology, Graft Survival drug effects, Graft Survival physiology, Humans, Kidney Transplantation immunology, Adrenal Cortex Hormones adverse effects, Graft Rejection prevention & control, Immunosuppressive Agents therapeutic use, Prednisone adverse effects
- Abstract
Steroids have numerous side effects, many occurring early posttransplantation with relatively low prednisone doses. Consequently, investigators have attempted steroid minimization or withdrawal. The first attempts at steroid minimization used early low-dose steroids and were associated with an increased rate of acute rejection episodes, late graft dysfunction, and graft loss. Subsequent studies, with cyclosporine-based immunosuppression, attempted steroid withdrawal late posttransplantation (>3 months) in highly selected, clinically well, and immunologically low-risk recipients. Again, steroid withdrawal was associated with an increased risk of acute rejection episodes and these episodes were associated with graft dysfunction and increased graft loss. The development of new powerful immunosuppressive agents has led to renewed attempts at late prednisone withdrawal. These also have been associated with increased late rejection risk. A more exciting innovation has been the attempts at rapid discontinuation (
- Published
- 2008
- Full Text
- View/download PDF